Shire Market Cap 2006-2018 | SHPG

Shire market cap history and chart from 2006 to 2018. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. Shire market cap as of November 09, 2018 is $54.81B.
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $54.806B $15.161B
Shire Pharmaceuticals Group plc is a specialty pharmaceutical company focused primarily on two therapeutic areas: central nervous system disorders and metabolic bone diseases. (press release)
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $45.773B 31.34
Grifols (GRFS) Spain $14.462B 17.65
Tilray (TLRY) United States $10.152B 0.00
Neurocrine Biosciences (NBIX) United States $9.559B 2108.20
Jazz Pharmaceuticals (JAZZ) Ireland $8.781B 12.60
Ionis Pharmaceuticals (IONS) United States $7.085B 0.00
Sage Therapeutics (SAGE) United States $6.139B 0.00
Impax Laboratories (AMRX) United States $5.895B 0.00
Nektar Therapeutics (NKTR) United States $5.888B 8.44
Catalent (CTLT) United States $5.453B 22.87
Loxo Oncology (LOXO) United States $5.106B 0.00
United Therapeutics (UTHR) United States $4.986B 8.15
Taro Pharmaceutical Industries (TARO) Israel $4.078B 15.10
FibroGen (FGEN) United States $3.574B 0.00
Endo (ENDP) Ireland $3.026B 4.64
USANA Health Sciences (USNA) United States $2.867B 24.40
Madrigal Pharmaceuticals (MDGL) United States $2.840B 0.00
Heron Therapeutics (HRTX) United States $2.212B 0.00
Aerie Pharmaceuticals (AERI) United States $2.171B 0.00
Xencor (XNCR) United States $2.130B 0.00
Pacira Pharmaceuticals (PCRX) United States $2.036B 275.11
Endocyte (ECYT) United States $1.934B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.819B 0.00
PTC Therapeutics (PTCT) United States $1.703B 0.00
Corcept Therapeutics (CORT) United States $1.502B 22.05
Enanta Pharmaceuticals (ENTA) United States $1.473B 18.01
Esperion Therapeutics (ESPR) United States $1.461B 0.00
Zogenix (ZGNX) United States $1.460B 0.00
Portola Pharmaceuticals (PTLA) United States $1.458B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.439B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.430B 0.00
TESARO (TSRO) United States $1.382B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.275B 0.00
Tricida (TCDA) United States $1.251B 0.00
TherapeuticsMD (TXMD) United States $1.173B 0.00
ImmunoGen (IMGN) United States $0.884B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.844B 0.00
Radius Health (RDUS) United States $0.715B 0.00
Karyopharm Therapeutics (KPTI) United States $0.704B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.645B 0.00
Flexion Therapeutics (FLXN) United States $0.642B 0.00
GlycoMimetics (GLYC) United States $0.573B 0.00
Collegium Pharmaceutical (COLL) United States $0.513B 0.00
Akebia Therapeutics (AKBA) United States $0.511B 0.00
ChemoCentryx (CCXI) United States $0.508B 40.20
Xeris Pharmaceuticals (XERS) United States $0.484B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.482B 0.00
Dova Pharmaceuticals (DOVA) United States $0.476B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.475B 0.00
Odonate Therapeutics (ODT) United States $0.466B 0.00
OptiNose (OPTN) United States $0.448B 0.00
Dermira (DERM) United States $0.445B 0.00
ArQule (ARQL) United States $0.435B 0.00
Aquestive Therapeutics (AQST) United States $0.424B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.423B 24.88
Zafgen (ZFGN) United States $0.419B 0.00
Siga Technologies (SIGA) United States $0.405B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.399B 0.00
Forty Seven (FTSV) United States $0.397B 0.00
Mast Therapeutics (SVRA) United States $0.382B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.378B 0.00
Concert Pharmaceuticals (CNCE) United States $0.376B 0.00
Minerva Neurosciences (NERV) United States $0.371B 0.00
Depomed (ASRT) United States $0.347B 12.93
Aclaris Therapeutics (ACRS) United States $0.329B 0.00
Tapimmune (MRKR) United States $0.325B 0.00
Aratana Therapeutics (PETX) United States $0.324B 0.00
KalVista Pharmaceuticals (KALV) United States $0.323B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.308B 0.00
CASI Pharmaceuticals (CASI) United States $0.297B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.296B 0.00
Translate Bio (TBIO) United States $0.293B 0.00
Majesco Entertainment (PTE) United States $0.288B 0.00
ElectroCore (ECOR) United States $0.267B 0.00
IMV INC (IMV) Canada $0.256B 0.00
Affimed (AFMD) Germany $0.253B 0.00
Opexa Therapeutics (ACER) United States $0.242B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.240B 0.00
MEI Pharma (MEIP) United States $0.233B 0.00
Ocular Therapeutix (OCUL) United States $0.228B 0.00
Aldeyra Therapeutics (ALDX) United States $0.221B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.215B 0.00
Lannett Co Inc (LCI) United States $0.209B 1.82
Tyme Technologies (TYME) United States $0.208B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.207B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.203B 0.00
Neon Therapeutics (NTGN) United States $0.202B 0.00
Galectin Therapeutics (GALT) United States $0.196B 0.00
Ardelyx (ARDX) United States $0.189B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.189B 0.00
Calithera Biosciences (CALA) United States $0.185B 0.00
Redhill Biopharma (RDHL) Israel $0.182B 0.00
Nature's Sunshine Products (NATR) United States $0.176B 0.00
ContraFect (CFRX) United States $0.174B 0.00
Molecular Templates (MTEM) United States $0.162B 0.00
Recro Pharma (REPH) United States $0.158B 0.00
Jounce Therapeutics (JNCE) United States $0.157B 0.00
Melinta Therapeutics (MLNT) United States $0.156B 0.00
Champions Oncology (CSBR) United States $0.154B 0.00
MediWound (MDWD) Israel $0.153B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.149B 0.00
DURECT (DRRX) United States $0.147B 0.00
Adherex Technologies (FENC) United States $0.145B 0.00
Infinity Pharmaceuticals (INFI) United States $0.136B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.132B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.131B 0.00
ProNAi Therapeutics (SRRA) Canada $0.123B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.115B 0.00
Cardiome Pharma (CORV) Canada $0.111B 0.00
Achaogen (AKAO) United States $0.104B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.100B 0.00
CTI BioPharma (CTIC) United States $0.099B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.089B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.085B 0.00
Iterum Therapeutics (ITRM) Ireland $0.080B 0.00
Neos Therapeutics (NEOS) United States $0.077B 0.00
Otonomy (OTIC) United States $0.076B 0.00
BioLineRx (BLRX) Israel $0.074B 0.00
Forward Pharma (FWP) Denmark $0.072B 0.00
Natural Alternatives (NAII) United States $0.072B 8.01
Immune Design (IMDZ) United States $0.071B 0.00
Novan (NOVN) United States $0.068B 0.00
Nivalis Therapeutics (ALPN) United States $0.066B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.065B 0.00
Genocea Biosciences (GNCA) United States $0.059B 0.00
Trillium Therapeutics (TRIL) Canada $0.049B 0.00
Capnia (SLNO) United States $0.047B 0.00
SCYNEXIS (SCYX) United States $0.045B 0.00
Avenue Therapeutics (ATXI) United States $0.044B 0.00
KemPharm (KMPH) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.040B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.037B 0.00
Heat Biologics (HTBX) United States $0.037B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
Lipocine (LPCN) United States $0.034B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Onconova Therapeutics (ONTX) United States $0.033B 0.00
Biomerica (BMRA) United States $0.028B 0.00
Xenetic Biosciences (XBIO) United States $0.025B 0.00
HANCOCK JAFFE (HJLI) United States $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.022B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.021B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.021B 7.50
Pain Therapeutics (PTIE) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Aviragen Therapeutics (VXRT) United States $0.019B 0.00
ESSA Pharma (EPIX) Canada $0.018B 0.00
Shineco (TYHT) China $0.017B 1.72
Aradigm (ARDM) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.014B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.013B 0.00
Skyline Medical (AIPT) United States $0.012B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.012B 0.00
Apricus Biosciences (APRI) United States $0.010B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
PharmAthene (ALT) United States $0.006B 0.00
Bio-Path Holdings (BPTH) United States $0.006B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.006B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.005B 0.00
Bio Blast Pharma (ORPN) Israel $0.005B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.004B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
RXi Pharmaceuticals (RXII) United States $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00